Investor Series: Opportunities in the Telehealth Market (Focus on [A] Need for Telehealth Solutions / Services, [B] Landscape of Key Innovators, [C] Analysis of Product Offerings and Affiliated Value Propositions, [D] Insights from Historical Funding Acti

Investor Series: Opportunities in the Telehealth Market (Focus on [A] Need for Telehealth Solutions / Services, [B] Landscape of Key Innovators, [C] Analysis of Product Offerings and Affiliated Value Propositions, [D] Insights from Historical Funding Activity, [E] Startup Health Indexing and Company Valuation Analysis, [F] Financial Analysis of Key Public Ventures, [G] Market Forecast and Opportunity Analysis, [H] Insights from Publicly Disclosed Investor Exits and [I] Key Acquisition Targets)

Telehealth refers to the remote delivery of healthcare services, such as medical consults, examination / interpretation of medical reports, critical health parameter monitoring, medical information sharing (between physicians and their patients) and patient education, using modern telecommunications solutions. In other words, it offers a convenient and cost-effective way for individuals with health problems to seek medical attention from the comfort of their respective homes. Currently, a wide variety of virtual conferencing tools and intuitive software are available for the aforementioned purposes. In fact, during the COVID-19 pandemic, due to the enforcement of mandatory social distancing practices, a lot of routine and emergency medical consultations were reported to have been conducted in the virtual environment. In 2020, it was estimated that 76% of hospitals in the US were using diverse telehealth technologies to connect doctors to patients. Although the demand for and use of telehealth technologies witnessed a notable surge (experts believe that the use of such solutions increased by around 40% compared to the pre-COVID era) during the recent pandemic, the idea of remote delivery of medical advice / information is believed to have been conceived much earlier. It is, therefore, safe to infer that the pandemic served to provide a much-needed impetus to drive the adoption of remote medical services. Moreover, even as social distancing mandates are being revoked across the world, the expanded access to quality healthcare offered by telemedicine is anticipated to continue to be used at a less unprecedented but evident scale.

The recent years have witnessed a surge in investment activity in companies involved in the development of telehealth solutions. This was primarily fueled by the demand for remote healthcare services, which led to a marked increase in the adoption of various telemedicine, health tracking and medical information sharing products. According to one of our recent studies, many companies are also engaged in providing tailored solutions, along with remote access to medical care facilities to patients. In addition, around 90% of the healthcare organizations are believed to have already invested or have revealed strong intentions to invest in remote patient monitoring systems. In the wake of the recent increase in demand, we believe that the market presents lucrative investment opportunities for investors on the lookout for both short- and long-term gains.

SCOPE OF THE REPORT
The “ Investor Series: Opportunities in the Telehealth Market” report provides detailed information on the telehealth industry, covering the core and peripheral products and affiliated services. It offers a technical and financial perspective on how the opportunity in this domain is likely to evolve, in terms of promising business ventures, over the coming decade. The information in this report has been presented across multiple deliverables, featuring interactive MS Excel sheets and an MS PowerPoint deck, which summarizes the key takeaways from the project, and insights drawn from the curated data. The report features the following detail s:
 A qualitative perspective on the current need for telehealth solutions and services, highlighting some of the key applications of such offerings and featuring information on the various companies that are engaged in this domain (along with details of some exemplary ventures that have either succeeded or failed in this market).
 A detailed analysis of telehealth focused companies that were established on or after 2005, featuring inputs on observed trends related to basic input parameters, such as year of establishment, headquarters, company size, and type of venture.
 A quantitative perspective on the relative health (based on basic company details, product details, financing activity, and estimated revenues and profits) of the different innovator companies that have been described in detail in this report. This analysis is based on a proprietary scoring criterion, informed via secondary research.
 An assessment of the various products and affiliated services, offered by the companies mentioned above, featuring analysis based on number and type of product, and an informed perspective on the value of the aforementioned offerings based on multiple relevant aspects, namely applicability and adoption trends, treatment-related value, value to patients, value to patients and healthcare professionals, and others.
 A company competitiveness analysis, offering a quantitative basis for comparing the diverse telehealth solutions captured in this report, based on the insights generated from the abovementioned analyses.
 A detailed analysis of the funding and investment activity that has taken place in this domain, since 2011. It also includes financing category-wise trends, describing the relative maturity (in terms of number of funding instances and total capital raised) of the key innovator companies discussed in the report. Further, it features a list of the leading investors in telehealth, based on their participation in financing activity in this domain.
 A proprietary analysis defining a basis for estimating the relative valuation of the private companies among the key innovators discussed in this report. Estimates presented in the report were based on information gathered via secondary research, for a sample set of companies. Key inferences drawn from the sample set were extrapolated using the appropriate mathematical models to generate valuation estimates for all companies in the dataset.
 An elaborate review of the overall telehealth market from a financial perspective, including detailed fundamental (insights from the balance sheet, and key financial ratios) and technical analyses (insights from historical and recent stock price variations, and analysis using popular stock performance indicators) of financial data of the publicly listed companies within the key innovators dataset.
 A business risk analysis, based on some of the major categories of risk that are usually discussed in the industry – namely operations-related risks, overall business-related risks, financial risks, product / technology associated risks, and social, economic, environmental and political risks.
 Case studies of instances where investors have exited various telehealth-related ventures, offering insights on returns on investment made (based on availability of data). Leveraging the abovementioned details, the report offers an informed opinion on the future outlook for investors in the telehealth market.
 A key acquisition targets analysis, based on the insights generated during the course of this study, highlighting some of the promising early-to-mid stage business ventures around which there is likely to be interest (in terms of acquisition potential).

One of the key objectives of the report was to evaluate the current opportunity and the future potential of the site management organizations market over the coming decades. We have provided an informed estimate of the likely evolution of the market in the short to mid-term and long term, for the period 2021-2035. The opportunity has been segregated on the basis of [A] key market segments (namely telemedicine (which further includes interactive patient care, store & forward telemedicine and remote patient monitoring offerings), patient portals and tele-education) and [B] geography (North America, Europe, Asia Pacific and the rest of the world). To account for future uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.

RESEARCH METHODOLOGY
The data presented in this report has been gathered via secondary research and analyzed using proprietary methods / tools, in order to develop a detailed perspective on the market landscape and the associated opportunity, across different global regions. As much as possible, the collated data has been checked for accuracy from multiple, reliable sources of information.

The secondary sources of information include
 Company websites
 Annual reports & SEC filings
 Investor presentations
 Industry specific equity research reports
 Industry databases
 Press releases
 Industry analysts’ views (as expressed on related news articles and other informative publications)

The insights presented are solely based on our knowledge, research and understanding of the relevant market, as inferred publicly available sources of information.

DELIVERABLE OUTLINES
Excel Deliver ables
Sheet I includes details on the key innovator companies captured in the report along with a summary dashboard, featuring interactive graphical representations of key insights generated from the company health indexing, value proposition analysis and company competitiveness analysis. This sheet also includes details of our proprietary key acquisition targets analysis.

Sheet II features a summary dashboard, including interactive graphical representations of some of the key insights generated related to the capital investments made in telehealth (since 2011) and our proprietary company valuation analysis (focused on the key innovator companies that have not yet gone public).

Sheet III is a summary of insights generated from a detailed fundamental and technical financial analysis, of publicly listed ventures in the key innovators dataset. It also offers a pictorial perspective on some of the major areas of risk associated with telehealth. It is worth mentioning that for each company, there is a separate MS Excel sheet, which provides information on key financial parameters and competitive insights based on historical and prevalent trends.

Sheet IV is a summary MS Excel dashboard, offering detailed graphical representations of the contemporary and future opportunity associated with telehealth. It also includes a collection of publicly available information on the investments made by select investors in companies that are now publicly listed. Based on the aforementioned information, the sheet offers a proprietary perspective on likely returns on investment received by the mentioned investors.

PowerPoint Deliverable: Key Section Outlines
Section I describes the current need for telehealth solutions and services, highlighting some of their key application areas. It includes information on the various companies that are engaged in this domain, along with details of some exemplary ventures that have either succeeded or failed in this market. It also features inputs from representatives from key stakeholder companies in this domain (as stated in publicly available articles and interview transcripts). The section concludes with information on the different conferences that have been conducted in this domain in the recent past.

The section also provides a [A] detailed analysis of telehealth focused innovator companies that were established on or after 2005. The section features basic company related details, such as year of establishment, headquarters, company size, and type of venture. It also includes [B] information on the various products and affiliated services, including analysis based on number and type of product, which are offered by the aforementioned companies. Based on the abovementioned insights, it offers a [C] quantitative perspective on the relative health (based on basic company details, product details, financing activity, and estimated revenues and profits) of the different innovator companies. In addition, it offers an informed perspective on the key [D] value proposition of the same companies based on multiple relevant aspects, namely applicability and adoption trends, treatment-related value, value to patients, value to patients and healthcare professionals, and others. Finally, based on the aforementioned inputs, the section features a detailed [E] company competitiveness analysis, offering a quantitative basis for comparing the diverse telehealth solutions captured in this report. It is worth mentioning that the analysis described in this section is based on proprietary scoring criteria, which was informed via secondary research.

Section II offers insights from a detailed [A] analysis of the funding and investment activity that has taken place in this domain, since 2011. It also includes financing category-wise trends, describing the relative maturity (in terms of number of funding instances and total capital raised) of the key innovator companies discussed in the report. Further, it features a proprietary basis for [B] estimating the relative valuation of the private companies among the key innovators discussed in this report. It is worth mentioning that the aforementioned estimations were based on information gathered via secondary research, for a sample set of companies. Key inferences drawn from the sample set were extrapolated using the appropriate mathematical models to generate valuation estimates for all companies in the dataset.

Section III is modelled in the likeness of an equity research report. It features a review of the overall telehealth market from a financial perspective and includes detailed fundamental (insights from the balance sheet, and key financial ratios) and technical analyses (insights from historical and recent stock price variations, and analysis using popular stock performance indicators) of financial data of six of the publicly listed companies within the key innovators dataset.

Section IV includes a business risk analysis, offering insights encompassing several known categories of risk; these include operations-related risks, business-related risks, product / technology risks, financial / asset-related risks, and other risks.

Section V features is an insightful market forecast analysis, highlighting the estimated current and future sizes of overall telehealth market till the year 2035. The opportunity has been segregated on the basis of [A] key market segments (namely telemedicine (which further includes interactive patient care, store & forward telemedicine and remote patient monitoring offerings), patient portals and tele-education) and [B] geography (North America, Europe, Asia Pacific and the rest of the world). It also includes case studies of instances where investors have exited various telehealth-related ventures, offering insights on returns on investment made (based on availability of data). Based on the abovementioned details, it provided an informed opinion on the future outlook for investors in the telehealth market.

Section VI offers insights from a proprietary analysis that leverages inputs from the startup health indexing and value proposition analysis (described in section I), to offer qualitative recommendations on companies that are likely to be perceived as key acquisition targets.

LIST OF COMPANIES / LIST OF COMPANIES AND ORGANIZATIONS

1. .406 Ventures
2. 14W
3. 20/20 HealthCare Partners
4. 415 Ventures
5. 7wire Ventures
6. 8VC
7. A.Capital
8. Aaron Patzer
9. AB Kinnevik
10. Abu Dhabi Investment Office
11. Accel
12. Accelerator
13. Access Industries
14. Acme Capital
15. ACRA
16. Acrew Capital
17. Acrew Capital’s Scout Fund
18. Activant Capital
19. Adam Balon
20. Adamed
21. Adaptive Healthcare Fund
22. Add Health Media
23. Affinity Capital Management
24. Air Angels
25. AirAngels
26. AirTree Ventures
27. Ajit Gunewardene
28. ALES Global Japan
29. Allianz X
30. Ally Bridge Group
31. Ally Bridge Group (ABG)
32. Alma Mundi Fund
33. Alma Mundi Ventures
34. Alphabet’s investment arm
35. Altimeter Capital
36. Alumni Ventures Group
37. Amazon
38. AME Cloud Ventures
39. American Investment Holdings
40. Amgen
41. Amgen Ventures
42. Amgen Ventures
43. Amit Bhatia
44. and Eliana Murillo
45. and Fosun Pharma
46. and New Capital Partners
47. and others.
48. and Skip Battle
49. and Starbucks
50. Andreessen Horowitz
51. Anne Wojcicki
52. Anshumani Ruddra
53. Anthem Health
54. Antonio Gracias
55. Ardea Capital Partners
56. Arizona Founders Fund
57. Arthur Ventures
58. Artis Ventures
59. Ascension Ventures
60. Asia Africa Investment & Consulting
61. Asia Partners
62. Aspect Ventures
63. Atento Capital
64. Athenahealth
65. Athensmed
66. Atlantic Labs
67. Atomico
68. Autonomous Ventures
69. Avalon Ventures
70. AWE Funds
71. AXA Venture Partners (AVP)
72. Axilor Ventures
73. Baidu Ventures
74. Baillie Gifford
75. Bain Capital Ventures
76. Bain Capital Ventures. Uprising
77. Baring Vostok
78. Barry Sternlicht
79. Bascom Ventures
80. Base10 Partners
81. Battery Ventures
82. Bayer
83. BDC Capital
84. Bessemer Venture Partners
85. Bill Ackman
86. Black Pearls VC
87. Blackbird
88. Blackbird Ventures
89. Blue Cross Blue Shield of Massachusetts
90. Blue Ivy Ventures
91. Blue Venture Fund
92. Blueprint Health
93. BlueRun Ventures
94. BOND
95. Bootstrap Incubation
96. Boston Millennia Partners
97. BoxGroup
98. BPEA
99. Bracket Capital
100. Breyer Capital
101. Bridges Israel
102. BrightEdge
103. Brown Angel Group
104. Burst Capital
105. Caisse de dépôt et placement du Québec (CDPQ)
106. California Health Care Foundation Innovation Fund
107. Cambia Health Solutions
108. Canaan Partners
109. Canada Pension Plan Investment Board
110. Canvas
111. Canvas Ventures
112. Capital Union Investments
113. Cardinal Partners
114. Casdin Capital
115. CDPQ
116. Centene
117. Centre for Innovation Incubation and Entrepreneurship (CIIE)
118. Cherif Habib
119. Chris Burch
120. CICC
121. Cigna Ventures
122. City Light Capital
123. Claes Dinkelspiel
124. Clark Valberg
125. Clearvision Equity
126. CMI Ventures
127. Collaborative Fund
128. Colle Capital Partners
129. Colorado Impact Fund
130. Comcast Ventures
131. Company Ventures
132. Compound Ventures
133. Connect the Grey Investment Management
134. Corisol Holding
135. Corisol Holdings
136. Correlation Ventures
137. Cowen Private Investments
138. Cox Enterprises
139. CQRS Limited
140. Creadev
141. Creandum
142. Creathor Ventures
143. Crosscut Ventures
144. CRV
145. CSIRO’s VC fund
146. CU Healthcare Innovation Fund
147. CU Healthcare Innovation Fund
148. Cumberland VC
149. D1 Capital Partners
150. Daniel Gulati
151. Dara Khosrowshahi
152. David Ellison
153. David H. Petraeus
154. Debiopharm Innovation Fund
155. Dedalus Group
156. Deena Shakir
157. Deerfield Management Company
158. Define Ventures
159. Demis Hassabis
160. DFJ
161. Digital Future
162. Digital Health Ventures
163. Dioko Health Ventures
164. Dioko Health Ventures
165. Discount Tech
166. Dr. Jeremy Lim
167. Dr. Mark Friedman
168. Dr. Rushika Fernandopoulle
169. Dragoneer Investment Group
170. Dreamers Fund
171. Drive Capital
172. dRx Capital
173. DRX Capital
174. DST Global
175. Dubai Angel Investors
176. Dundee Venture Capital
177. e.ventures
178. Early Light Ventures
179. EASME - EU Executive Agency for SMEs
180. Echo Health
181. Echo Health Ventures
182. ECMC
183. EDBI
184. Eight Roads Ventures
185. Emily Melton
186. Emmett Partners
187. Eniac Ventures
188. Equity Venture Partners
189. ERGO Fund
190. Eric Schmidt’s Innovation Endeavors
191. ES Investor
192. Esther Dyson
193. Euclidean Capital
194. European Commission
195. Exponent
196. F Cubed
197. Faber Ventures
198. Fairview Health Services
199. Female Founders Fund
200. Fidelity Management & Research
201. Fidelity Management & Research Company
202. FinSight Ventures
203. FinX Capital
204. First Ascent Ventures
205. First Trust Capital Partners
206. FirstMark Capital
207. FirstTime.
208. FJ Labs
209. FLAG Capital Management
210. Flashpoint Venture Capital
211. Flint Capital
212. Florian Jansen
213. Fosun Pharma
214. Founders Fund
215. F-Prime Capital
216. F-Prime Capital
217. F-Prime Capital Partners
218. Francisco Partners
219. Freestyle Capital
220. Frist Cressey Ventures
221. Future Perfect Ventures
222. Gaingels
223. GAN
224. GAN Ventures
225. Gates Foundation
226. GE Ventures
227. General Atlantic
228. General Catalyst
229. Geoff Price
230. George Ruan
231. GGV Capital
232. GlaxoSmithKline
233. Global Voyager Fund
234. Glynn Capital Management
235. Goldman Sachs Investment Partners
236. Goldman Sachs Merchant Banking Division
237. Goldman Sachs’ merchant banking
238. Goodwater Capital
239. Google Cloud
240. Google Ventures
241. Google’s VC
242. Gradient Ventures
243. Grand Central Tech Ventures
244. Great Oaks VC
245. Great Oaks Venture Capital
246. Green Innovations
247. Greenspring Associates
248. Groupe Arnault
249. GSMA Ecosystem Accelerator
250. GSR Ventures
251. Guidewell
252. GuideWell Mutual Holding Corporation
253. GV
254. GV
255. Hacking Health Accelerator.
256. Hambrecht Ducera Growth Ventures
257. Harmony Partners
258. Harri Tilev
259. Hashtag One
260. Hawke Ventures
261. HBM Healthcare Investment
262. HBM Healthcare Investments
263. Headwater VC
264. Health Catalyst Capital
265. Health Velocity Capital
266. HealthInvest Equity Partners
267. HEALTHY VENTURES
268. Henley Business Angels
269. Heritage Medical Systems
270. Heritage Provider Network
271. Highline
272. Highmark Ventures
273. Hikma Ventures
274. HIMAngel
275. HLM Venture Partners
276. HLM Ventures
277. Holtzbrinck Ventures
278. Horizon 2020 SME support program.
279. Horizon BlueCross BlueShield of New Jersey
280. Howard Jenkins
281. Hoxton Ventures
282. HPE Growth
283. Huajin Fund
284. Humana
285. Hustle Fund
286. Hyde Park Venture Partners
287. Hyperplane Capital
288. Icon Ventures
289. IDFC Alternatives
290. Idinvest Partners
291. iGlobe Partners
292. IHH Healthcare
293. Illumina
294. Illumina Ventures
295. Impact Investments
296. including Optum Ventures
297. Index Ventures
298. Indie.vc
299. Inflection Capital
300. Ingleside Investors
301. Inkef Capital
302. INKEF Capital
303. InnoVen Capital
304. InnoVision Capital
305. Insight Partners
306. Intel Capital
307. International Finance Corporation (IFC)
308. InvAscent
309. Inventus Capital
310. IRA Capital
311. Israeli Innovation Authority
312. Ithmar Capital Partners
313. J.P. Morgan
314. Jackson Square Ventures
315. JAFCO Asia Fund
316. Jafco Ventures
317. Jamie McCourt
318. Jason Calacanis
319. Jawed Karim
320. Jeff Weiner
321. Jefferson Health System
322. Jeremy Andrus
323. Jeremy Yap
324. Jerry Yang
325. Jim Foreman
326. John Simon
327. Jon Wright
328. Jonathan Bush
329. June Fund
330. Justin Kan
331. Kae Capital
332. Kae Capital
333. Kaiser Permanente Ventures
334. Kaiser Permanente Ventures and Illumina Ventures
335. Kamet Capital
336. Kamet Capital Partners
337. Ken Goulet
338. Ken Griffin
339. Kenneth Griffin
340. Kevin Hill
341. Kevin Scott
342. Khosla Ventures
343. Khosla Ventures
344. Khosla Ventures.
345. Kickstart Seed Fund
346. Kim Hammonds
347. Kima Ventures
348. Kinnevik
349. Kleiner Perkins
350. Kleiner Perkins Caufield & Byers
351. Kleiner Perkins Caufield and Byers
352. Kustaa Piha
353. L Catterton
354. LabCorp
355. Lachy Groom
356. Lanka Orix Leasing Company
357. Lead Edge Capital
358. Len Blavatnik’s global investment group
359. Leonard Lynch
360. Lerer Hippeau
361. Lerer Hippeau Ventures
362. Lerer Ventures
363. LetsVenture
364. LifeSci Ventures
365. Lightspeed Venture Partners
366. Lightspeed Venture Partnersl
367. Lightspeed Ventures
368. LionBird
369. Lionel Richie
370. Liquid 2 Ventures
371. LLC
372. Lori Goler
373. LPs Bill
374. LRVHealth
375. Lux Capital
376. Lux Capital
377. M25
378. M25 Group
379. MadhanKumar Madathupalayam
380. MAF Mauritius
381. Main Sequence Ventures
382. Manatt Venture Fund
383. March Capital
384. Mark Leslie
385. Martin Ventures
386. Matrix Partners
387. Matt Mullenweg
388. Maven Ventures
389. Maverick Capital Ventures
390. Maverick Ventures
391. Mayfield Fund
392. Maynard Webb
393. Medical Angels investment group
394. Mellon and QuestMark Partners
395. MemorialCare Innovation Fund (MCIF)
396. Merck Global Health Innovation Fund
397. Mercury Fund
398. Metamorphic Ventures
399. Metsola Ventures
400. Michael Stoppelman
401. Microsoft
402. Microsoft Ventures
403. Mike Silagadze
404. Mike Wortsman
405. Mikhail Sokolov
406. Mikhail Tsyferov
407. Milliways Ventures
408. Mindy Kaling
409. MK Capital
410. Mohr Davidow Ventures
411. Montage Ventures
412. Morado Ventures
413. Morningside Ventures
414. MPM Capital
415. MPOF Mauritius
416. Mubadala Ventures
417. Mustafa Suleyman
418. Nat Turner
419. Natalie Portman
420. Nathan and Sonia Baschez
421. Nathan Kirsh
422. Natie Kirsh
423. National Bank of Canada
424. National Center for Research and Development
425. National Institutes of Health
426. New Capital Partners and Trident Capital
427. New Enterprise Associates
428. New Enterprise Association
429. new investors Blue Cloud Ventures
430. New York Angels
431. NewFlight
432. NewView Capital
433. NEXT Canada
434. Next Ventures
435. Next Wave Impact Fund
436. NextView Ventures
437. NGP Capital
438. NGP Capital.
439. Nikhil Krishnan
440. Nokia Growth
441. Norwest Venture Partners
442. Norwest Venture Partners
443. Norwest Venture Partners
444. Notation Capital
445. Novartis
446. Novartis Venture Fund
447. Novo Holdings
448. Novotech Health Holdings
449. Oak HC/FT
450. Obvious Ventures
451. Obvious Ventures
452. Olive Tree Ventures
453. Omidyar Network
454. Omphalos Venture Partners
455. Omphalos Ventures
456. Ontario Centres of Excellence
457. Ontario Teachers’ Pension Plan
458. operational VC
459. Optum Ventures. Centene Corporation
460. Orbimed
461. OrbiMed Israel Partners
462. ORIX Growth Capital
463. ORIX Healthcare Capital
464. Orpah Winfrey
465. Owl Ventures
466. Oxeon Investments
467. Palm Drive Capital
468. Parkview Investment Advisors
469. Patrick J. Kennedy.
470. Patrick Spain
471. Paul Buchheit
472. Paul Jaobs
473. Pavilion Capital
474. Pelion Venture Partners
475. Per Båtelson
476. Perceptive Advisors
477. Peterson Ventures
478. Philips
479. Phoenix Ventures
480. physician-led MEDA Angels
481. PinPoint Ventures
482. PKO VC
483. Portag3 Ventures
484. PPD
485. PPD
486. PPD
487. Precursor Ventures
488. Prime Capital
489. Princeville Global
490. Pritzker Capital
491. Pritzker Group Venture Capital
492. Prodeko Ventures
493. Programa
494. Project A
495. Project A Ventures
496. Project A.
497. Qualcomm Ventures
498. Questa Capital
499. Questa Capital Management
500. Qumra Capital
501. Qura
502. Qure
503. Rand Capital
504. Randor
505. Reaktor Ventures
506. Real Ventures
507. Rebright Partners
508. Redmile Group
509. Redwood Global Healthcare Fund
510. Reese Witherspoon
511. Revolution Growth
512. Richard Park
513. Richard Reed
514. Ridgeview Asset Management
515. Right Side Capital Management
516. RLJ Equity Partners
517. Roche Venture Fund
518. Rockies Venture Club
519. Rockies Venture Fund
520. Rohini Pandhi
521. Rohit M.A.
522. Romulus Capital
523. Rucker Park Capital
524. Rushan Venture Capital
525. Rushika Fernandopulle
526. Rustic Canyon Partners
527. Safeguard Scientifics
528. Sami Inkinen
529. Samsung Catalyst Fund
530. Sand Hill Angels
531. Sanofi
532. Sanofi Ventures
533. Sanofi-Genzyme BioVentures
534. Sapphire Ventures
535. Saudi Arabia’s Public Investment Fund
536. Saudi’s Athaal Group
537. SBK Tech Ventures
538. Scale AI
539. SEI Ventures
540. Sequoia
541. Sequoia Capital
542. Sequoia Capital India
543. Seraph Group
544. Sergey Brin
545. Service Provider Capital
546. Seyen Capital
547. Shakopee
548. Shasta Ventures
549. Shasta Ventures
550. Shea Ventures
551. Sherpa Ventures
552. Sierra Ventures
553. SignalFire
554. Signia Venture Partners
555. Silicon Valley Bank
556. Silver Lake Waterman
557. Silverton Partners
558. Sir Richard Branson
559. Slauson & Co.
560. Slow Ventures
561. Soft Bank
562. Softbank
563. SoftBank
564. Sogou
565. Soma Capital
566. Sound Ventures
567. Spark Capital
568. SpeedUp Venture Capital Group
569. Spring Lake Equity Partners
570. Spring Mountain Capital
571. Spring Mountain Capital
572. Sputnik ATX
573. SputnikATX Ventures
574. Square Peg
575. Stage 2 Capital
576. Stanford Health Care
577. Starting Line
578. Startup Health
579. Sterling’s capital
580. Steve Shulman
581. Steven Cohen
582. Storm Ventures
583. Streamlined Ventures
584. Streamlined Ventures.
585. Streamlined Ventures.
586. Stride Ventures
587. Structure Capital
588. Summation Health Ventures
589. Sun Life
590. Susan Lyne
591. SV Angel
592. Takeda
593. Taru Kapoor
594. Tata Group
595. TDJ Pitango Ventures
596. TEAMFund LP
597. Tech Council Venture
598. Techstars
599. Teladoc Health
600. Tenaya Capital
601. Tencent
602. Tesi
603. Teuza
604. The American Cancer Society
605. the Colorado Impact Fund
606. The Council
607. The Daube Family office
608. The Family
609. The Jump Fund
610. The Living Fund.
611. The Mayfield Fund
612. The Valley Fund
613. The Cooperative Research Centre Project
614. TheTime
615. Thomas Lehrman
616. Three Fields Capital
617. Three Leaf Ventures
618. Tiger Global and Qumra Capital
619. TKS I
620. Tobias Lütke
621. Todd Cozzens
622. Tom Meredith
623. Tony Fadell's Future Shape
624. Town Hall Ventures
625. Transformation Capital
626. Trans-Pacific Technology Fund
627. Trident Capital
628. TrueSight Ventures
629. Trustbridge
630. TT Capital Partners
631. Tull Investment Group
632. Tusk Venture Partners
633. Tusk Venture Partners
634. TVC Capital
635. Two Sigma Ventures
636. Two Sigma Ventures
637. TYLT Labs
638. UC San Francisco
639. Union Square Ventures
640. Uniqa Ventures
641. Unitus Ventures
642. University Growth Fund
643. Unpopular Ventures
644. Unseen Capital
645. Urban Capital Network
646. Vega Ventures
647. Velocity
648. Venrock
649. Venture Catalysts
650. Venture Founders
651. Vertical Venture Partner
652. Vesalius Biocapital
653. Vesalius Biocapital and Faber
654. Vesalius Biocapital III
655. Vida Ventures
656. Vir Kashyap
657. VMG Partners
658. VNV Global
659. Vostok New Ventures
660. W23
661. Walgreens
662. Walgreens Boots Alliance
663. Wallenberg Foundation
664. Walter Capital National Bank of Canada
665. Walter Financial
666. Walter Ventures
667. Wanxiang America Corporation
668. Waterline Ventures
669. Waypoint Capital Partners
670. Webb Investment Network
671. Wefunder
672. WELL Health Technologies
673. Westcap
674. Western Technology Investment
675. WestTech Ventures
676. White Star Capital
677. Whittier Ventures
678. Wild Ventures
679. William Tunstall-Pedoe
680. Wittington Ventures
681. Workday Ventures
682. World Innovation Lab Venrock
683. WTI and other unnamed individual investors
684. WuXi Healthcare Ventures
685. Xfund
686. Y Combinator
687. Yahoo founder Jerry Yang’s AME Cloud Ventures
688. Yandex
689. Yuri Milner
690. Zac Weinberg
691. Zaffre Investments
692. Ziegler LinkAge Fund

Please note that the publisher limits purchases by consulting clients to either Consulting Company Team License or Global Site License for Entire Company. Any other selections will not be fulfilled by this publisher.